Zhengfang Liu

VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR

Cheng Liu, Li Liu, Kun Wang et al. · Oncogene · 2020 · 59 citations

Medicine, Cancer Biology, Oncology +10

Grape Seed Proanthocyanidin Extract Ameliorates Diabetic Bladder Dysfunction via the Activation of the Nrf2 Pathway

Yaofeng Zhu, Zhifeng Liu, Zhaoyun Gao et al. · PLoS ONE · 2015 · 54 citations · Full text

Life Sciences, Botany, Pharmacology +13

TP53 alterations of hormone-naïve prostate cancer in the Chinese population

Zhengfang Liu, Hu Guo, Yaofeng Zhu et al. · Prostate Cancer and Prostatic Diseases · 2020 · 51 citations · Full text

Medicine, Oncology, Urology +14

Sunitinib treatment promotes metastasis of drug-resistant renal cell carcinoma via TFE3 signaling pathway

Luchao Li, Shuo Zhao, Zhengfang Liu et al. · Cell Death and Disease · 2021 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC

Xiaofeng Li, Zhengfang Liu, Chuanyou Xia et al. · Cancer Letters · 2021 · 41 citations · Full text

Medicine, Cancer Biology, Molecular Biology +9